Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

B-Cell Lymphomas

Known as: lymphoma b-cell, cell b lymphoma, b cell lymphomas 
A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow… Expand
National Institutes of Health

Related topics

Related topics

37 relations
50 ML rituximab 10 MG/ML InjectionAtypical lymphocyteB-LymphocytesBMI1 gene
Expand

Narrower (1)

Burkitt Lymphoma

Broader (1)

Lymphoma, Non-Hodgkin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Advances in cancer immunotherapy 2019 – latest trends
Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2019
Review
2019
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.
Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment for hematologic malignancies. Two CAR T-cell… Expand
Is this relevant?
Review
2019
Review
2019
Mechanisms of resistance to CAR T cell therapy
  • N. Shah, T. Fry
  • Nature Reviews Clinical Oncology
  • 2019
    • Corpus ID: 71145129
The successes with chimeric antigen receptor (CAR) T cell therapy in early clinical trials involving patients with pre-B cell… Expand
  • figure 1
  • table 1
  • table 2
Is this relevant?
Review
2019
Review
2019
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
Chimeric antigen receptor (CAR) T‐cell therapy represents a major advancement in personalized cancer treatment. In this strategy… Expand
Is this relevant?
Review
2019
Review
2019
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
Primary cutaneous lymphomas are a heterogeneous group of T- and B-cell lymphomas that present in the skin with no evidence of… Expand
Is this relevant?
Review
2019
Review
2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
Summary Background Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2019
Review
2019
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Abstract Background Patients with diffuse large B-cell lymphoma that is refractory to primary and second-line therapies or that… Expand
Is this relevant?
Review
2018
Review
2018
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a fatal malignancy known as adult T-cell leukemia (ATL… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2018
Review
2018
The impacts of H. pylori virulence factors on the development of gastroduodenal diseases
Although most H. pylori infectors are asymptomatic, some may develop serious disease, such as gastric adenocarcinoma, gastric… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2018
Review
2018
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
In October 2017, the FDA granted regular approval to axicabtagene ciloleucel, a CD19-directed chimeric antigen receptor (CAR) T… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE